<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
 <LINK HRef="../CSS/ggrcm.css" Rel="stylesheet" Type="text/css">
 <META name="description" content="Incr&eacute;tinomim&eacute;tiques (analogues du GLP-1)">
 <META name="keywords" content="Incr&eacute;tinomim&eacute;tiques (analogues du GLP-1), R&eacute;pertoire Comment&eacute; des M&eacute;dicaments (C.B.I.P. aslb)">
 <META name="GGR_Kruimelpad" content=" Systeme hormonal / Diabete / ">
 <META name="GGR_HyrTree" content="5.1.6.">
 <cfinclude template="/include/SPC.cfm"/>
  <script SRC="/JS/jquery-1.3.2.min.js"></script>
  <script SRC="/JS/jquery.qtip-1.0.0-rc3.min.js"></script>
  <!---script SRC="/JS/qTip_FR.js"></script--->
 <TITLE>Incr&eacute;tinomim&eacute;tiques (analogues du GLP-1)</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0" id="bodykw">
 <A Name="TopOfPage"></A>

  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%"><A HRef="../HeaderTxt/LeCBIP.htm">Le C.B.I.P.</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/NousContacter.htm">Nous contacter</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/Liens.htm">Sites Int&eacute;ressantes</A></TD>
   </TR> 
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%" Class="footer">Bon &agrave; savoir</TD>
    <TD Width="30%"><A HRef="../Index.htm"><B>Le R&eacute;pertoire</B></A></TD>
    <TD Width="30%" Class="footer">Folia</TD>
   </TR> 
   <TR> 
    <TD ColSpan="4"><HR></TD>
   </TR> 
  </TABLE> 

 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
  <TR>
   <TD vAlign="top" Width="260">
  <!--- begin van linker "tafel" met TOC --->
    <TABLE Width="260" Border="0" CellPadding="0" CellSpacing="0" BgColor="#DEFFD6" style="border: solid #000000 1px">
     <TR>
      <TD ColSpan="3" Align="center" BgColor="#008000">
       <FONT Face="Arial" Size="2" Color="#FFFFFF"><STRONG>Table des mati&egrave;res</STRONG></FONT></TD>
     </TR>
     <TR>
      <TD Width="3">&nbsp;</TD>
      <TD Width="256">
       <TABLE Width="100%" Border="0" CellPadding="2" CellSpacing="0">
        <TR>
         <TD  Colspan="2"><IMG SRC="../Images/Pixel_Transp.gif" Alt="" Width="1" Height="5" Border="0"></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">&nbsp;</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="/GGR/Index_Intro.cfm" Class="toc">Introduction</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">1.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_A.htm" Class="toc">Syst&egrave;me cardio-vasculaire</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">2.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_B.htm" Class="toc">Sang et coagulation</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">3.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_C.htm" Class="toc">Syst&egrave;me gastro-intestinal</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">4.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_D.htm" Class="toc">Syst&egrave;me respiratoire</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.</TD>
         <TD vAlign="top" Class="toc"><A HRef="../MPG/MPG_E.htm" Class="toc">Syst&egrave;me hormonal</A></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.1.</TD>
         <TD vAlign="top" Class="toc"><A HRef="../MPG/MPG_EA.htm" Class="toc">&nbsp;Diab&egrave;te</A></TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr" BgColor="#FFFF99">5.1.6.</TD>
         <TD vAlign="top" Class="toc" BgColor="#FFFF99">&nbsp;&nbsp;Incr&eacute;tinomim&eacute;tiques (analogues du GLP-1)</TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.1.6.1.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_EAFA" Class="toc">&nbsp;&nbsp;&nbsp;Albiglutide</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.1.6.2.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_EAFB" Class="toc">&nbsp;&nbsp;&nbsp;Ex&eacute;natide</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.1.6.3.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_EAFC" Class="toc">&nbsp;&nbsp;&nbsp;Liraglutide</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">5.1.6.4.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="#MPG_EAFD" Class="toc">&nbsp;&nbsp;&nbsp;Lixis&eacute;natide</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">6.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_F.htm" Class="toc">Gyn&eacute;co-obst&eacute;trique</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">7.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_G.htm" Class="toc">Syst&egrave;me urog&eacute;nital</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">8.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_H.htm" Class="toc">Douleur et fi&egrave;vre</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">9.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_I.htm" Class="toc">Pathologies ost&eacute;o-articulaires</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">10.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_J.htm" Class="toc">Syst&egrave;me nerveux</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">11.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_K.htm" Class="toc">Infections</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">12.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_L.htm" Class="toc">Immunit&eacute;</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">13.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_M.htm" Class="toc">M&eacute;dicaments antitumoraux</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">14.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_N.htm" Class="toc">Min&eacute;raux, vitamines et toniques</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">15.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_O.htm" Class="toc">Dermatologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">16.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_P.htm" Class="toc">Ophtalmologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">17.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_Q.htm" Class="toc">Oto-Rhino-Laryngologie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">18.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_R.htm" Class="toc">Anesth&eacute;sie</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">19.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_S.htm" Class="toc">Agents de diagnostic</A><BR>
         </TD>
        </TR>
        <TR>
         <TD vAlign="top" Align="Right" Class="tocnr">20.</TD>
         <TD vAlign="top" Class="toc">
          <A HRef="../MPG/MPG_T.htm" Class="toc">M&eacute;dicaments divers</A><BR>
         </TD>
        </TR>
       </TABLE>
       <BR>
      </TD>
     </TR>
    </TABLE>
    <DIV class="normal_font">&nbsp; <strong>Nom de sp&eacute;cialit&eacute;:</strong></DIV>
    <table border="0" cellspacing="2" cellpadding="1" align="center">
     <tr>
      <td align=center class="letter"><A href="../Merk/MP_A.htm" class="letterlink">&nbsp;A&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_B.htm" class="letterlink">&nbsp;B&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_C.htm" class="letterlink">&nbsp;C&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_D.htm" class="letterlink">&nbsp;D&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_E.htm" class="letterlink">&nbsp;E&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_F.htm" class="letterlink">&nbsp;F&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_G.htm" class="letterlink">&nbsp;G&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_H.htm" class="letterlink">&nbsp;H&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_I.htm" class="letterlink">&nbsp;I&nbsp;</A></td>
     </tr><tr>
      <td align=center class="letter"><A href="../Merk/MP_J.htm" class="letterlink">&nbsp;J&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_K.htm" class="letterlink">&nbsp;K&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_L.htm" class="letterlink">&nbsp;L&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_M.htm" class="letterlink">&nbsp;M&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_N.htm" class="letterlink">&nbsp;N&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_O.htm" class="letterlink">&nbsp;O&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_P.htm" class="letterlink">&nbsp;P&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Q.htm" class="letterlink">&nbsp;Q&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_R.htm" class="letterlink">&nbsp;R&nbsp;</A></td>
     </tr><tr>
      <td align=center class="letter"><A href="../Merk/MP_S.htm" class="letterlink">&nbsp;S&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_T.htm" class="letterlink">&nbsp;T&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_U.htm" class="letterlink">&nbsp;U&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_V.htm" class="letterlink">&nbsp;V&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_W.htm" class="letterlink">&nbsp;W&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_X.htm" class="letterlink">&nbsp;X&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Y.htm" class="letterlink">&nbsp;Y&nbsp;</A></td>
      <td align=center class="letter"><A href="../Merk/MP_Z.htm" class="letterlink">&nbsp;Z&nbsp;</A></td>
     </tr>
    </table>
    <DIV class="normal_font">&nbsp; <strong>Principe actif</strong></DIV>
    <table border="0" cellspacing="2" cellpadding="1" align="center">
     <TR>
      <TD Class="letter" Align="center"><A HRef="../Stof/IN_A.htm" Class="letterlink">&nbsp;A&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_B.htm" Class="letterlink">&nbsp;B&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_C.htm" Class="letterlink">&nbsp;C&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_D.htm" Class="letterlink">&nbsp;D&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_E.htm" Class="letterlink">&nbsp;E&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_F.htm" Class="letterlink">&nbsp;F&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_G.htm" Class="letterlink">&nbsp;G&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_H.htm" Class="letterlink">&nbsp;H&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_I.htm" Class="letterlink">&nbsp;I&nbsp;</A></TD>
     </TR><TR>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_J.htm" Class="letterlink">&nbsp;J&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_K.htm" Class="letterlink">&nbsp;K&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_L.htm" Class="letterlink">&nbsp;L&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_M.htm" Class="letterlink">&nbsp;M&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_N.htm" Class="letterlink">&nbsp;N&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_O.htm" Class="letterlink">&nbsp;O&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_P.htm" Class="letterlink">&nbsp;P&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Q.htm" Class="letterlink">&nbsp;Q&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_R.htm" Class="letterlink">&nbsp;R&nbsp;</A></TD>
     </TR><TR>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_S.htm" Class="letterlink">&nbsp;S&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_T.htm" Class="letterlink">&nbsp;T&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_U.htm" Class="letterlink">&nbsp;U&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_V.htm" Class="letterlink">&nbsp;V&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_W.htm" Class="letterlink">&nbsp;W&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_X.htm" Class="letterlink">&nbsp;X&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Y.htm" Class="letterlink">&nbsp;Y&nbsp;</A></TD>
      <TD Class="letter" Align="center"><A HREF="../Stof/IN_Z.htm" Class="letterlink">&nbsp;Z&nbsp;</A></TD>
     </TR>
    </TABLE>

   </TD>
<!--- einde van linker "tafel" met TOC --->

<!--- tussen kolommetje --->
   <TD Width="20"></TD>

<!--- begin van rechter "tafel" met ThGrp en M info --->
   <TD vAlign="top">
   
    <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
     <TR> 
      <TD RowSpan="2" Width="10"></TD>
      <TD Width="70%"><STRONG><FONT Face="Arial" Size="2">R&eacute;pertoire Comment&eacute; des M&eacute;dicaments</FONT></STRONG></TD> 
      <TD Width="29%" Align="Right" Class= "Datum">&nbsp;
       Avril 2015&nbsp;&nbsp;
      </TD>
      <TD Rowspan="2" Width="10"></TD>
     </TR>
     <TR>
      <TD Colspan="2"><HR Width="100%" Size="1" Color="green" NOSHADE></TD>
     </TR>
    </TABLE>

    <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
     <TR>
      <TD Width="10"><A Name="TiCv00444"></A>&nbsp;</TD>
      <TD><H2>Incr&eacute;tinomim&eacute;tiques (analogues du GLP-1)</H2></TD>
      <TD Width="10">&nbsp;</TD>
     </TR>
     <TR>
      <TD Width="10">&nbsp;</TD>
      <TD vAlign="top">
<!---    Start van de HYR->INTRO informatie blok--->
<P Class="Text">L'albiglutide, l'ex&eacute;natide, le liraglutide et le lixis&eacute;natide sont des analogues de l'hormone incr&eacute;tine <I>glucagon-like peptide-1</I> (GLP-1); il s'agit d'une hormone intestinale qui assure le contr&ocirc;le glyc&eacute;mique, en ralentissant la vidange gastrique, en diminuant la lib&eacute;ration du glucagon par les cellules &alpha; du pancr&eacute;as, et en stimulant la lib&eacute;ration d'insuline glucose-d&eacute;pendante par les cellules &beta;.</P>
<A Name="Topic_A"><B>Positionnement</B></A><UL Class="Text"> <LI Class="Text"><I><A Class="text" HREF="MPG_EA.htm">Voir 5.1.</A></I></LI> <LI Class="Text">Les incr&eacute;tinomim&eacute;tiques sont g&eacute;n&eacute;ralement utilis&eacute;s en association &agrave; d'autres m&eacute;dicaments hypoglyc&eacute;miants. Contrairement &agrave; l'insuline, leur utilisation s'accompagne d'une diminution du poids corporel. Leur effet sur les complications &agrave; long terme du diab&egrave;te n'est pas connu [voir Folia de f&eacute;vrier 2008 <I>et</I> mai 2013].</LI> <LI Class="Text">Etant donn&eacute; le risque limit&eacute; d'hypoglyc&eacute;mie, l'utilisation d'incr&eacute;tinomim&eacute;tiques peut &ecirc;tre envisag&eacute;e chez les patients chez qui les hypoglyc&eacute;mies repr&eacute;sentent un risque important (p. ex. les chauffeurs professionnels).</LI></UL>
<A Name="Topic_B"><B>Indications</B></A><UL Class="Text"> <LI Class="Text">Diab&egrave;te de type 2 en association &agrave; d'autres antidiab&eacute;tiques, ou en monoth&eacute;rapie pour l'albiglutide [<I>voir Folia de mai 2015</I>].</LI> <LI Class="Text">Ces m&eacute;dicaments ne sont rembours&eacute;s que dans le cadre de certaines trith&eacute;rapies (<A Class="text" Target="_blank" HREF="http://www.cbip.be">voir www.cbip.be</A Class="text" Target="_blank"> ou <A Class="text" Target="_blank" HREF="http://www.inami.be">www.inami.be</A Class="text" Target="_blank">).</LI></UL>
<A Name="Topic_C"><B>Contre-indications principales</B></A><UL Class="Text"> <LI Class="Text"><B>Grossesse et allaitement.</B></LI> <LI Class="Text">Insuffisance r&eacute;nale grave.</LI></UL>
<A Name="Topic_D"><B>Effets ind&eacute;sirables principaux</B></A><UL Class="Text"> <LI Class="Text">Troubles gastro-intestinaux, surtout des naus&eacute;es: fr&eacute;quent.</LI> <LI Class="Text">Hypoglyc&eacute;mie, surtout en association &agrave; un sulfamid&eacute; hypoglyc&eacute;miant (ou &agrave; une insuline basale).</LI> <LI Class="Text">Oed&egrave;me angioneurotique, anaphylaxie: tr&egrave;s rare</LI> <LI Class="Text">R&eacute;actions au site d'injection (plus fr&eacute;quent avec les formes hebdomadaires).</LI> <LI Class="Text">Un risque accru de pancr&eacute;atite et de cancer du pancr&eacute;as et de la thyro&iuml;de a &eacute;t&eacute; sugg&eacute;r&eacute;, mais on ne dispose actuellemet pas de preuves d&rsquo;un lien de causalit&eacute; [voir Folia de novembre 2014].</LI> <LI Class="Text">Formation d&rsquo;anticorps, avec diminution possible de l&rsquo;effet hypoglyc&eacute;miant et risque accru de r&eacute;actions au site d&rsquo;injection.</LI> <LI Class="Text">Liraglutide: troubles thyro&iuml;diens, hypercalciton&eacute;mie: rare.</LI></UL>
<A Name="Topic_T"><B>Grossesse et allaitement</B></A><UL Class="Text"> <LI Class="Text"><I><A Class="text" HREF="MPG_EA.htm">Voir 5.1.</A></I></LI> <LI Class="Text"><B>La grossesse et l'allaitement sont des contre-indications.</B></LI></UL>
<A Name="Topic_E"><B>Interactions principales</B></A><UL Class="Text"> <LI Class="Text"><I><A Class="text" HREF="MPG_EA.htm">Voir 5.1.</A></I></LI> <LI Class="Text">Ralentissement de la vidange gastrique avec modification possible de la vitesse d'absorption d'autres m&eacute;dicaments.</LI></UL>
<A Name="Topic_F"><B>Pr&eacute;cautions principales</B></A><UL Class="Text"> <LI Class="Text">La prudence s&rsquo;impose en cas de gastropar&eacute;sie diab&eacute;tique et d&rsquo;insuffisance r&eacute;nale mod&eacute;r&eacute;e &agrave; s&eacute;v&egrave;re.</LI> <LI Class="Text">Une r&eacute;duction de la dose du sulfamid&eacute; hypoglyc&eacute;miant ou de l&rsquo;insuline basale peut &ecirc;tre envisag&eacute;e pour r&eacute;duire le risque d'hypoglyc&eacute;mie.</LI></UL>
<A Name="Topic_W"><B>Administration et posologie</B></A><UL Class="Text"> <LI Class="Text">Les incr&eacute;tinomim&eacute;tiques sont administr&eacute;s &agrave; dose fixe par voie sous-cutan&eacute;e.</LI></UL>
<!---    Start van de MP blok(ken)--->
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv02114"></A><A Name="MPG_EAFA"><B>Albiglutide</B></A></P>
     <TABLE Class="MPGposol_MPG" Width="100%">
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG"><B>Posologie</B></TD>
      </TR>
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG">30 &agrave; 50 mg par semaine en 1 injection<BR></TD>
      </TR>
     </TABLE>

       <BR>
       <A Name="MP_06078"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Eperzan
         <FONT Class="IR_MPG">(GSK)</FONT></TD>
         <TD Width="30"><A HRef="http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F40F07F" Class="PT_MPG" Target="_Top"><IMG Width="10" Height="10" Border="0" SRc="../Images/BT.gif" onmouseover="this.T_WIDTH=120;return escape('Pharmacovigilance renforcée. Plus de détails? <B>Cliquez ici</B>')"></A></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[albiglutide]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">cartouche ser. s.c.</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><IMG SRC="../Images/EMPTY.gif" Width="12" Height="15" Align="absmiddle"><IMG SRC="../Images/EMPTY.gif" Width="6"  Height="10" Align="absmiddle" Border="0"></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EAFA.htm#Vos_06029" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 3198207<BR><B>CTI</B>: 457795<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">4 x&nbsp;30mg / 0,5ml </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/3198207A4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/A4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 98,39</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><IMG SRC="../Images/EMPTY.gif" Width="12" Height="15" Align="absmiddle"><IMG SRC="../Images/EMPTY.gif" Width="6"  Height="10" Align="absmiddle" Border="0"></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EAFA.htm#Vos_06028" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 3198215<BR><B>CTI</B>: 457982<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">4 x&nbsp;50mg / 0,5ml </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/3198215A4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/A4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 98,39</TD>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv01757"></A><A Name="MPG_EAFB"><B>Ex&eacute;natide</B></A></P>
     <TABLE Class="MPGposol_MPG" Width="100%">
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG"><B>Posologie</B></TD>
      </TR>
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG">10 &agrave; 20 &micro;g p.j. en 2 injections; pour lib. prolong&eacute;e, 2 mg en 1 injection sous-cutan&eacute;e 1 x par semaine<BR></TD>
      </TR>
     </TABLE>

       <BR>
       <A Name="MP_05816"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Bydureon
         <FONT Class="IR_MPG">(AstraZeneca)</FONT></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[ex&eacute;natide [microsph&egrave;res]]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">flacon s.c.</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/11/696/001&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/11/696/001&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EAFB.htm#Vos_05866" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 3073467<BR><B>CTI</B>: 407714<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">4 x&nbsp;2mg  +  0,65 ml ser. solv.</TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/3073467A4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/A4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 98,47</TD>
        </TR>
        <TR>
         <TD Colspan="5" Class="MpNote_MPG"> (forme &agrave; lib&eacute;ration prolong&eacute;e)</TD>
        </TR>
       </TABLE>

       <BR>
       <A Name="MP_03401"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Byetta
         <FONT Class="IR_MPG">(AstraZeneca)</FONT></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[ex&eacute;natide]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">cartouche ser. s.c.</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/362/001&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/362/001&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EAFB.htm#Vos_01966" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2385409<BR><B>CTI</B>: 292984<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top"> 60 doses&nbsp;5µg / dose </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/2385409A4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/A4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 104,84</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/362/003&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/06/362/003&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EAFB.htm#Vos_01954" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2385417<BR><B>CTI</B>: 293002<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top"> 60 doses&nbsp;10µg / dose </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/2385417A4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/A4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 104,84</TD>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv01758"></A><A Name="MPG_EAFC"><B>Liraglutide</B></A></P>
     <TABLE Class="MPGposol_MPG" Width="100%">
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG"><B>Posologie</B></TD>
      </TR>
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG">0,6 &agrave; 1,8 mg p.j. en 1 injection<BR></TD>
      </TR>
     </TABLE>

       <BR>
       <A Name="MP_04937"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Victoza
         <FONT Class="IR_MPG">(Novo Nordisk)</FONT></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30" Class="MP_MPG">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[liraglutide [biosynth&eacute;tique]]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">cartouche ser. s.c.</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/09/529/002&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/09/529/002&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EAFC.htm#Vos_03346" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 2652121<BR><B>CTI</B>: 346622<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">2 x&nbsp;18mg / 3ml </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/2652121A4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/A4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 105,92</TD>
        </TR>
       </TABLE>
<!---    Start van de MP blok(ken)--->
       <P><A Name="Ticv01978"></A><A Name="MPG_EAFD"><B>Lixis&eacute;natide</B></A></P>
     <TABLE Class="MPGposol_MPG" Width="100%">
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG"><B>Posologie</B></TD>
      </TR>
      <TR>
       <TD Colspan="5" Class="MPGposol_MPG">10 &agrave; 20 &micro;g p.j. en 1 injection<BR></TD>
      </TR>
     </TABLE>

       <BR>
       <A Name="MP_05731"></A>
       <TABLE Width="500" Border="0" CellSpacing="0" CellPAdding="0">
        <TR BgColor="#DEFFD6">
         <TD Width="320" Class="MP_MPG">Lyxumia
         <FONT Class="IR_MPG">(Sanofi-Aventis)</FONT></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30"><A HRef="http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F40F07F" Class="PT_MPG" Target="_Top"><IMG Width="10" Height="10" Border="0" SRc="../Images/BT.gif" onmouseover="this.T_WIDTH=120;return escape('Pharmacovigilance renforcée. Plus de détails? <B>Cliquez ici</B>')"></A></TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="30">&nbsp;</TD>
         <TD Width="25"  Align="center">
         <A HRef="#TopOfPage"><IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A></TD>
        </TR>
       </TABLE>
       <TABLE Class="Mpp_MPG" Width="500" CellPadding="0" CellSpacing="0" Border="0">
        <TR><TD Colspan="5">&nbsp;</TD></TR>
        <TR>
         <TD Class="InNm_MPP" ColSpan="5" ALign="left">[lixis&eacute;natide]</TD>
        </TR>
        <TR>
         <TD Class="Mpp_MPG" Colspan="5" Align="left">cartouche ser. s.c.</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/12/811/001&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/12/811/001&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EAFD.htm#Vos_05829" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 3017423<BR><B>CTI</B>: 434454<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">1 x 14 doses&nbsp;10µg / dose </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/3017423A4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/A4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 46,60</TD>
        </TR>
        <TR BgColor="#E2F3E1" vAlign="Bottom">
         <TD Width="28"><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/12/811/003&leafletType=rcp"><IMG SRC="../Images/FAGG.gif" Width="12" Height="15" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('RCP<BR>source:<B>AFMPS</B>')"></A><A HRef="http://bijsluiters.fagg-afmps.be/registrationSearchServlet?key=EU/1/12/811/003&leafletType=leafletFR"><IMG SRC="../Images/FAGG.gif" Width="6" Height="10" Border="0" Align="absmiddle" Class="SPC" onmouseover="return escape('notice patient<BR>source: <B>AFMPS</B>')"></A></TD>
         <TD Width="30"><A HRef="../PVT/PVT_EAFD.htm#Vos_05828" Class="PT_MPG"><IMG SRC="../Images/Euro.gif" Width="15" Height="15" Border="0" Align="absmiddle" onmouseover="return escape('<B>CNK</B>: 3017431<BR><B>CTI</B>: 434472<BR>Comparer les prix? <B>Cliquez ici</B>')"></A></TD>
         <TD Class="Mpp_MPG" Width="275" Align="left" vAlign="top">2 x 14 doses&nbsp;20µg / dose </TD>
         <TD Class="Mpp_MPG" Width="20" Align="left"><IMG Width="14" Height="16" SRC="../Images/RX.gif" Alt="" Border="0" Align="AbsMiddle" vAlign="Top"></TD>
         <TD Class="Mpp_MPG" Width="80" Align="right"><A HREF="../RIZIV/3017431A4.htm"><IMG vAlign="Top" Width="14" Height="16" SRC="../Images/A4.gif" onmouseover="return escape('a priori<BR>plus de d&eacute;tails?<BR><B>Cliquez ici</B>')" Border="0"></A><A href="http://www.cbip.be/nieuws/artikel.cfm?welk=150" Target="_top"><IMG SRC="../Images/Merkprodukt.gif"    border="0" width="16" Height="16" vAlign="Top" Align="absmiddle" onmouseover="return escape('M&eacute;dicament <B>sans</B> suppl&eacute;ment au ticket mod&eacute;rateur, mais <B>pas</B> en cat&eacute;gorie bon march&eacute;')"></A></TD>
         <TD Class="Mpp_MPG" Width="80"  vAlign="top" Align="right">&euro; 87,99</TD>
        </TR>
       </TABLE>
<!---
       <P Class="datum">
       <A Href="#TopOfPage">
        <IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A>&nbsp;</P>
--->
      </TD>
      <TD Width="10">&nbsp;</TD>
     </TR>
    </TABLE>
    <BR>
 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
  <TR>
   <TD Align="center">
    <HR WIDTH="90%" SIZE="1" COLOR="#008000" NOSHADE>
    <SPAN Class="footer">
 Centre Belge d 'Information Pharmacoth&eacute;rapeutique (C.B.I.P. asbl) <BR>
 c/o Heymans Instituut, De Pintelaan 185, 9000 Gent<BR>
 </SPAN>
 <A HRef="" Target="_top" Class="footer_link"><font color="#0000FF"></font></A> -
 <A HRef="mailto:redaction@cbip.be" Class="footer_link"><font color="#0000FF">redaction@cbip.be</font></A>
 - <A HRef="../Headertxt/Avertissement.htm" target="_blank" class="footer_link"><FONT Color="#0000FF">Avertissement / Disclaimer</FONT></A>
   </TD>
  </TR>
 </TABLE>
<!--- einde van de rechter "tafel" met MP info--->

   </TD>
  </TR>
 </TABLE>
<script language="JavaScript" type="text/javascript" SRC="../JS/wz_tooltip.js"></script>
</BODY>
</HTML>
<CFINCLUDE template="/search/incHighLightScriptJQuery.cfm">
